Oppenheimer & CO Inc Sol Gel Technologies Ltd. Transaction History
Oppenheimer & CO Inc
- $6.42 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding SLGL
# of Institutions
22Shares Held
5.35MCall Options Held
1.5KPut Options Held
0-
Phoenix Holdings Ltd. Givatayim, L32.47MShares$1.33 Million0.03% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.1.23MShares$662,8750.01% of portfolio
-
Harel Insurance Investments & Financial Services Ltd.920KShares$496,9790.01% of portfolio
-
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3229KShares$123,7560.03% of portfolio
-
Prosperity Wealth Management, Inc. San Ramon, CA163KShares$88,2360.04% of portfolio
About Sol-Gel Technologies Ltd.
- Ticker SLGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,129,500
- Market Cap $12.5M
- Description
- Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...